These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23266723)

  • 1. Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice.
    Walker GV; Gilbert MR; Prabhu SS; Brown PD; McAleer MF
    J Neurooncol; 2013 Mar; 112(1):83-9. PubMed ID: 23266723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of patients with primary gliosarcoma treated with concomitant and adjuvant temozolomide: A single institutional analysis of 27 cases.
    Rath GK; Sharma DN; Mallick S; Gandhi AK; Joshi NP; Haresh KP; Gupta S; Julka PK
    Indian J Cancer; 2015; 52(4):599-603. PubMed ID: 26960490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
    Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
    J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric gliosarcoma treated with adjuvant radiotherapy and temozolomide.
    Mallick S; Gandhi AK; Sharma DN; Gupta S; Haresh KP; Rath GK; Julka PK
    Childs Nerv Syst; 2015 Dec; 31(12):2341-4. PubMed ID: 26438548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution.
    Gerstein J; Franz K; Steinbach JP; Seifert V; Rödel C; Weiss C
    Strahlenther Onkol; 2011 Nov; 187(11):722-8. PubMed ID: 22037649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary gliosarcoma--clinical experience from a regional cancer centre in north India.
    Biswas A; Kumar N; Kumar P; Vasishta RK; Gupta K; Sharma SC; Patel F; Mathuriya SN
    Br J Neurosurg; 2011 Dec; 25(6):723-9. PubMed ID: 21591852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.
    Cao JQ; Fisher BJ; Bauman GS; Megyesi JF; Watling CJ; Macdonald DR
    J Neurooncol; 2012 Apr; 107(2):395-405. PubMed ID: 22105851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
    Yung WK; Albright RE; Olson J; Fredericks R; Fink K; Prados MD; Brada M; Spence A; Hohl RJ; Shapiro W; Glantz M; Greenberg H; Selker RG; Vick NA; Rampling R; Friedman H; Phillips P; Bruner J; Yue N; Osoba D; Zaknoen S; Levin VA
    Br J Cancer; 2000 Sep; 83(5):588-93. PubMed ID: 10944597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma survival in the United States before and during the temozolomide era.
    Johnson DR; O'Neill BP
    J Neurooncol; 2012 Apr; 107(2):359-64. PubMed ID: 22045118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series.
    Castelli J; Feuvret L; Haoming QC; Biau J; Jouglar E; Berger A; Truc G; Gutierrez FL; Morandi X; Le Reste PJ; Thillays F; Loussouarn D; Nouhaud E; Crehange G; Antoni D; Vauleon E; de Crevoisier R; Noel G
    J Neurooncol; 2016 Aug; 129(1):85-92. PubMed ID: 27169763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model.
    Masi BC; Tyler BM; Bow H; Wicks RT; Xue Y; Brem H; Langer R; Cima MJ
    Biomaterials; 2012 Aug; 33(23):5768-75. PubMed ID: 22591609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic management of gliosarcoma in the temozolomide era.
    McAleer MF; Brown PD
    CNS Oncol; 2015; 4(3):171-8. PubMed ID: 25905568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.
    Sher DJ; Henson JW; Avutu B; Hochberg FH; Batchelor TT; Martuza RL; Barker FG; Loeffler JS; Chakravarti A
    J Neurooncol; 2008 May; 88(1):43-50. PubMed ID: 18231723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study.
    Shawky H; Abo Hamar AH; Galal S; Zakaria F; El-Shorbagy D
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):107-19. PubMed ID: 21057562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
    Prados MD; Chang SM; Butowski N; DeBoer R; Parvataneni R; Carliner H; Kabuubi P; Ayers-Ringler J; Rabbitt J; Page M; Fedoroff A; Sneed PK; Berger MS; McDermott MW; Parsa AT; Vandenberg S; James CD; Lamborn KR; Stokoe D; Haas-Kogan DA
    J Clin Oncol; 2009 Feb; 27(4):579-84. PubMed ID: 19075262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
    Krauze AV; Myrehaug SD; Chang MG; Holdford DJ; Smith S; Shih J; Tofilon PJ; Fine HA; Camphausen K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):986-992. PubMed ID: 26194676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group.
    Cohen KJ; Pollack IF; Zhou T; Buxton A; Holmes EJ; Burger PC; Brat DJ; Rosenblum MK; Hamilton RL; Lavey RS; Heideman RL
    Neuro Oncol; 2011 Mar; 13(3):317-23. PubMed ID: 21339192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme.
    Guckenberger M; Mayer M; Buttmann M; Vince GH; Sweeney RA; Flentje M
    Strahlenther Onkol; 2011 Sep; 187(9):548-54. PubMed ID: 21858417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.
    Rusthoven CG; Koshy M; Sher DJ; Ney DE; Gaspar LE; Jones BL; Karam SD; Amini A; Ormond DR; Youssef AS; Kavanagh BD
    JAMA Neurol; 2016 Jul; 73(7):821-8. PubMed ID: 27214765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.